Nonulcer dyspepsia

Current Opinion in Gastroenterology

Volumn 14, Issue 6, 1998, Pages 447-451

  Hammer, Johann ^a   Talley, Nicholas J ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ABDOMINAL PAIN; DIGESTIVE SYSTEM FUNCTION DISORDER; DYSPEPSIA; ELECTROGASTROGRAPHY; ERADICATION THERAPY; GASTROSCOPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; QUALITY OF LIFE; REVIEW; STOMACH EMPTYING; SYMPTOM;

EID: 0032467964     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-199811010-00005     Document Type: Review

References (48)

1. Rosenstock S, Kay L, Rosenstock C, Andersen LP, Bonnevie O, Jørgensen T: Relationship between Helicobacter pylori infection and gastrointestinal symptoms and syndromes. Gut 1997, 41:169-176. A longitudinal survey for gastrointestinal symptoms and their relation to H. pylori infection in a Danish population. Patients with increased levels of IgG antibodies were more likely to have upper gut symptoms at 5 years of follow-up.
2. Braden B, Caspary WF, Lembcke B: Density of gastric Helicobacter pylori colonization is not associated with occurrence of dyspeptic symptoms. Dig Dis Sci 1997, 42:2120-2123.
3. Goh KL: Prevalence of and risk factors for Helicobacter pylori infection in a multiracial dyspeptic Malaysian population undergoing endoscopy. J Gastroenterol Hepatol 1997, 12(suppl):S29-S35.
4. Gilvarry J, Buckley MJ, Beattie S, Hamilton H, O'Morain CA: Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia. Scand J Gastroenterol 1997, 32:535-540. Symptomatic improvement after 1 year of follow-up was achieved after H. pylori eradication, but only in patients with ulcer-like nonulcer dyspepsia. Persistent H. pylori infection was associated with persistent upper gut symptoms.
5. Van der Hulst RWM, Van der Ende A, Dekker FW, Ten Kate FJW, Weel JFL, Keller JJ, Kruizinga SP, Dankert J, Tytgat GNJ: Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1 -year follow-up study. Gastroenterology 1997, 113:25-30. Eradication of H. pylori did not improve intestinal metaplasia and gastric mucosal atrophy at 1 year of follow-up. Symptom alleviation was not evaluated.
6. Xia H-X, Talley NJ, Keane CT, O'Morain CA: Recurrence of Helicobacter pylori infection after successful eradication. Nature and possible causes. Dig Dis Sci 1997, 42:1821-1834.
7. Talley NJ, Hunt RH: What role does Helicobacter pylori play in dyspepsia and nonulcer dyspepsia? Arguments for and against H. pylori being associated with dyspeptic symptoms. Gastroenterology 1997, 113:S67-S77. A comprehensive review of the evidence for and against a role of H. pylori in upper gastrointestinal symptoms in nonulcer dyspepsia. Potential mechanisms by which H. pylori could induce dyspepsia are discussed.
8. Veldhuyzen van Zanten SJO: Commentary: bleeding ulcers, interaction between NSAIDs and Helicobacter pylon infection, and nonulcer dyspepsia. Gastroenterology 1997, 113:S90-S92.
9. Freston JW: What remaining questions regarding Helicobacter pylori and associated diseases should be addressed by future research? Gastroenterology 1997, 113:S163-S166.
10. Axon A, Forman D: Helicobacter gastroduodenitis: a serious infectious disease. BMJ 1997, 314:1430-1431.
11. Labenz J, Malfertheiner P: Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor? Gut 1997, 41:277-280. Review of the association of H. pylori and gastroesophageal reflux disease. The mechanisms by which H. pylori might influence the clinical outcome of gastroesophageal reflux disease are also discussed.
12. Froehlich F, Gonvers J-J, Beglinger C: Has the time now arrived to eradicate Helicobacter pylori routinely in non-ulcer dyspepsia? Eur J Gastroenterol Hepatol 1997, 9:917.
13. Schwartz DN, Ofman JJ, Kahrn KL: Management of Helicobacter pylori-positive patients with dyspepsia. Ann Intern Med 1997, 127:244.
14. De Boer WA, Buckley MJM, O'Morain CA: Helicobacter pylori and non-ulcer dyspepsia. Scand J Gastroenterol 1997, 32:1183-1184.
15. Malfertheiner P, McColl K, Baldi F, Dinelli M, Festi D, Parente F, Ricciardiello L, Roda E, Scarpulla G, Stanghellini V, et al.: Update on Helicobacter pylori research. Dyspepsia. Eur J Gastroenterol Hepatol 1997, 9:624-625.
16. Koch KL: Dyspepsia of unknown origin: pathophysiology, diagnosis, and treatment. Dig Dis 1997, 15:316-329.
17. Agreus L, Talley NJ: Challenges in managing dyspepsia in general practice. BMJ 1997, 315:1284-1288. Reviews the concept of testing for and treating H. pylori in dyspepsia, and the pitfalls of serologic testing.
18. Graham DY, Oderda G, Rapa A, Chiorbioli, Caradonna M, Bona G, Van Doom L-J, Quint W, Schneeberger P, Tytgat GJ, et al.: The only good Helicobacter pylori is a dead Helicobacter pylori. Lancet 1997, 350:71-71.
19. Lawson JM: Predicting endoscopic diagnosis in the dyspeptic patient: untying a Gordian knot. Gastrointest Endosc 1997, 46:583-584.
20. Heading RC, Wager E, Tooley PJH: Reliability of symptom assessment in dyspepsia. Eur J Gastroenterol Hepatol 1997, 9:779-781.
21. Vaira D, Stanghellini V, Menegatti M, Palli D, Corinaldesi R, Miglioli M: Prospective screening of dyspeptic patients by Helicobacter pylori serology: a safe policy? The Italian Helicobacter pylori study group. Endoscopy 1997, 29:595-601.
22. Bytzer P: Can noninvasive Helicobacter pylori testing save endoscopy? Endoscopy 1997, 29:649-651.
23. Maeda S, Kanai F, Ogura K, Yoshida H, Ikenoue T, Takahashi M, Kawabe T, Shiratori Y, Omata M: High seropositivity of anti-cagA antibody in Helicobacter pylori-infected patients irrelevant to peptic ulcers and normal mucosa in Japan. Dig Dis Sci 1997, 42:1841-1847.
24. Takata T, Fujimoto S, Anzai K, Shirotani T, Okada M, Sawae Y, Ono J: Analysis of the expression of CagA and VacA and the vacuolating activity in 167 isolates from patients with either peptic ulcers or non-ulcer dyspepsia. Am J Gastroenterol 1998, 93:30-34.
25. Heikkinen M, Janatuinen E, Mayo K, Megraud F, Julkunen R, Pikkarainen P: Usefulness of anti-Helicobacter pylori and anti-CagA antibodies in the selection of patients for gastroscopy. Am J Gastroenterol 1997, 92:2225-2229.
26. American Gastroenterological Association medical position statement: evaluation of dyspepsia. Gastroenterology 1998, 114:579-581.
27. Talley NJ, Silverstein MD, Agréus L, Nyrén O, Sonnenberg A, Holtmann G: AGA technical review: evaluation of dyspepsia. Gastroenterology 1998, 114:582-595. A review of the literature that was the basis for the American Gastroenterological Association medical position statement for the evaluation of dyspepsia [26].
28. Christie J, Shepherd NA, Codling BW, Valori RM: Gastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsia. Gut 1997, 41:513-517.
29. Stanghellini V, Tosetti C, Corinaldesi R: Symptoms and gastric functions in dyspepsia-goodbye to gastroparesis or to inadequate studies? Neurogastroenterol Mot 1997, 9:203-204.
30. Fock KM, Khoo TK, Chia KS, Sim CS: Helicobacter pylori infection and gastric emptying of indigestible solids in patients with dysmotility-like dyspepsia. Scand J Gastroenterol 1997, 32:676-680.
31. Maes BD, Ghoos Y, Hiele MI, Rutgeerts PJ: Gastric emptying rate of solids in patients with non-ulcer dyspepsia. Dig Dis Sci 1997, 42:1158-1162.
32. Tung CF, Chang CS, Chen GH, Kao CH, Wang SJ: Comprehensive gastric emptying study for type-II diabetes mellitus dyspeptic patients. Scand J Gastroenterol 1997, 32:884-887.
33. Wilmer A, Van Cutsem E, Andrioli A, Tack J, Coremans G, Janssens J: Ambulatory gastrojejunal manometry in severe motility-like dyspepsia: lack of correlation between dysmotility, symptoms, and gastric emptying. Gut 1998, 42:235-242.
34. Talley NJ, Colin-Jones D, Koch KL, Koch M, Nyrén O, Stanghellini V: Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterol Int 1991, 4:145-160.
35. Hausken T, Søndenaa K, Svebak S, Gilja OH, Olafsson S, Ødegaard S, Søreide O, Berstad A: Common pathogenetic mechanisms in symptomatic, uncomplicated gallstone disease and functional dyspepsia. Volume measurement of gallbladder and antrum volume using three-dimensional ultrasonography. Dig Dis Sci 1997, 42:2505-2512.
36. Pfaffenbach B, Adamek RJ, Bartholomäus C, Wegener M: Gastric dysrhythmias and delayed gastric emptying in patients with functional dyspepsia. Dig Dis Sci 1997, 42:2094-2099.
37. Parkman HP, Miller MA, Trate D, Knight LC, Urbain JL, Maurer AH, Fisher RS: Electrogastrography and gastric emptying scintigraphy are complementary for assessment of dyspepsia. J Clin Gastroenterol 1997, 24:214-219.
38. Di Lorenzo C, Reddy SN, Flores AF, Hyman PE: Is electrogastrography a substitute for manometric studies in children with functional gastrointestinal disorders? Dig Dis Sci 1997, 42:2310-2316.
39. Holtmann G, Goebell H, Jockenhoevel F, Talley NJ: Altered vagal and intestinal mechanosensory function in chronic unexplained dyspepsia. Gut 1998, 42:501-506. Vagal function, measured by an indirect test, seems to be impaired in nonulcer dyspepsia.
40. Holtmann G, Goebell H, Talley NJ: Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis? Am J Gastroenterol 1997, 92:954-959.
41. Bennett EJ, Piesse C, Palmer K, Badcock C-A, Tennant CC, Kellow JE: Functional gastrointestinal disorders: psychological, social, checkand somatic features. Gut 1998, 42:414-420. A study investigating the association between functional gastrointestinal disorders and psychosocial factors. Specific psychosocial disturbances were identified for different subgroups of dyspepsia.
42. De Boer WA: Diagnosis of Helicobacter pylori infection. Review of diagnostic techniques and recommendations for their use in different clinical settings. Scand J Gastroenterol 1997, 32(suppl 223):35-42.
43. Duggan R, Robinson RJ, Stone MA, Mayberry JF, Delaney B, Hobbs FDR, Wilson S, Johnston BT, Dawes M, et al.: Validation of a rapid whole blood test for diagnosing Helicobacter pylori infection. BMJ 1997, 314:1688-1690.
44. 14C-urea breath test in determining Helicobacter pylori status and predicting ulcer disease in dyspeptic patients. Am J Gastroenterol 1998, 93:20-25.
45. Sihvo S, Hemminki E: Self-medication of dyspepsia: how appropriate is it? Scand J Gastroenterol 1997, 32:855-861.
46. Read NW, Abitbol JL, Bardhan KD, Whorvell PJ, Fraitag B: Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia. Gut 1997, 41:664-668.
47. Talley NJ: Visceral analgesics and functional dyspepsia: have we found the Holy Grail? Gut 1997, 41:717-718.
48. Mertz H, Fass R, Kodner A, Yan-Go F, Fullerton S, Mayer EA: Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 1998, 93:160-165.